Ticker Details
Aligos Therapeutics, Inc.
IPO Date:	October 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$42.95M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 4.39%
Avg Daily Range (30 D):	$0.27 | 3.70%
Avg Daily Range (90 D):	$0.40 | 4.65%

Institutional Daily Volume
Avg Daily Volume:	.05M
Avg Daily Volume (30 D):	.04M
Avg Daily Volume (90 D):	.06M

Trade Size
Avg Trade Size (Sh.):	38
Avg Trade Size (Sh.) (30 D):	72
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	103
Avg Institutional Trade:	$2.37M
Avg Institutional Trade (30 D):	$1.07M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.3M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$.69M
Avg Closing Volume:	13.54K

News

Mar 5, 2026 @ 1:00 PM Aligos Therapeutics Reports Recent Business Progre... Source: Aligos Therapeutics, Inc.

Feb 23, 2026 @ 1:00 PM Aligos Therapeutics Presents Positive Data at the ... Source: Not Specified

Jan 30, 2026 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Na

Dec 12, 2025 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Jordyn Tarazi

Nov 14, 2025 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Jordyn Tarazi

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.45	$-2.01	$-2.45
Diluted EPS	$-2.45	$-2.01	$-2.45
Revenue	$2.19M	$.17M	$2.19M
Gross Profit
Net Income / Loss	$-24.19M	$-19.88M	$-24.19M
Operating Income / Loss	$-87.99M	$-21.81M	$-87.99M
Cost of Revenue
Net Cash Flow	$-18.69M	$-23.64M	$-18.69M
PE Ratio

Splits
Aug 19, 2024	1:25